Skip to main content

Takeda Pharmaceutical Co Ltd Value Stock - Dividend - Research Selection

Takeda pharmaceutical

ISIN: JP3463000004 , WKN: 853849

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Takeda Pharmaceutical Company Limited ist ein in Japan ansässiges Pharmaunternehmen. Das Segment Ethical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceuticals (R & D), Arzneimittel, Arzneimittel, Arzneimittel, Arzneimittel, Arzneimittel für die klinische Forschung, Arzneimittel für Osteoporose-Medikamente, Antibiotika, Allergie-Medikamente, Vitamin- Tropfen und Impfstoffe, unter anderem. Das Segment Healthcare produziert und vertreibt allgemeine Medikamente und Medikamente sowie Quasi-Medikamente. Das Segment Sonstige ist ein Unternehmen, das sich mit der Entwicklung und dem Vertrieb von Arzneimitteln beschäftigt. Zum 31. März 2014 hatte die Gesellschaft 146 Tochtergesellschaften und 17 assoziierte Unternehmen.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS